Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PI 16:0/22:5)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003751 AN006158 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Blood Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006158 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Urine Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006159 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Blood Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006159 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Urine Human Kidney disease Universidad CEU San Pablo LC-MS
ST003103 AN005077 Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach Blood Human COVID-19 Universidad CEU San Pablo GC-MS/LC-MS
ST003103 AN005078 Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach Blood Human COVID-19 Universidad CEU San Pablo GC-MS/LC-MS
ST002956 AN004853 An application of automated LLE extraction in determine the age and HFD effects in adult mice in metabolomic, lipidomic, and proteomic Blood Mouse Calico Life Sciences LC-MS
ST002101 AN003435 Functional metabolomics-based molecular profiling of acute and chronic hepatitis (Liver Lipidomics) Liver Mouse NASH Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University LC-MS
  logo